Doximity, Inc.

NYSE:DOCS Stock Report

Market Cap: US$11.1b

Doximity Management

Management criteria checks 3/4

Doximity's CEO is Jeff Tangney, appointed in Apr 2010, has a tenure of 15.17 years. total yearly compensation is $298.87K, comprised of 98.7% salary and 1.3% bonuses, including company stock and options. directly owns 26.51% of the company’s shares, worth $2.93B. The average tenure of the management team and the board of directors is 4.3 years and 9.8 years respectively.

Key information

Jeff Tangney

Chief executive officer

US$298.9k

Total compensation

CEO salary percentage98.71%
CEO tenure15.2yrs
CEO ownership26.5%
Management average tenure4.3yrs
Board average tenure9.8yrs

Recent management updates

Recent updates

At US$52.56, Is Doximity, Inc. (NYSE:DOCS) Worth Looking At Closely?

May 17
At US$52.56, Is Doximity, Inc. (NYSE:DOCS) Worth Looking At Closely?

Calculating The Intrinsic Value Of Doximity, Inc. (NYSE:DOCS)

May 01
Calculating The Intrinsic Value Of Doximity, Inc. (NYSE:DOCS)

Doximity: Strong Platform, Growth Proof Needed For Valuation Comfort

Apr 30

Shareholders Are Optimistic That Doximity (NYSE:DOCS) Will Multiply In Value

Apr 04
Shareholders Are Optimistic That Doximity (NYSE:DOCS) Will Multiply In Value

What Doximity, Inc.'s (NYSE:DOCS) 28% Share Price Gain Is Not Telling You

Feb 23
What Doximity, Inc.'s (NYSE:DOCS) 28% Share Price Gain Is Not Telling You

Doximity Q3 Earnings: Outpacing Even Management's Expectations

Feb 10

When Should You Buy Doximity, Inc. (NYSE:DOCS)?

Jan 24
When Should You Buy Doximity, Inc. (NYSE:DOCS)?

Doximity: Upgraded To Buy Amid Promising Growth And Strong Execution

Jan 13

Here's Why We Think Doximity (NYSE:DOCS) Is Well Worth Watching

Jan 06
Here's Why We Think Doximity (NYSE:DOCS) Is Well Worth Watching

Doximity: Strong Fundamentals And Growth Potential Makes It Attractive

Dec 06

Doximity (NYSE:DOCS) Knows How To Allocate Capital

Dec 01
Doximity (NYSE:DOCS) Knows How To Allocate Capital

Earnings Not Telling The Story For Doximity, Inc. (NYSE:DOCS) After Shares Rise 34%

Nov 13
Earnings Not Telling The Story For Doximity, Inc. (NYSE:DOCS) After Shares Rise 34%

Does This Valuation Of Doximity, Inc. (NYSE:DOCS) Imply Investors Are Overpaying?

Nov 02
Does This Valuation Of Doximity, Inc. (NYSE:DOCS) Imply Investors Are Overpaying?

Is Doximity, Inc. (NYSE:DOCS) Potentially Undervalued?

Oct 15
Is Doximity, Inc. (NYSE:DOCS) Potentially Undervalued?

Doximity: Downgrade To Hold On Valuation Concerns

Oct 03

Here's Why Doximity (NYSE:DOCS) Has Caught The Eye Of Investors

Sep 23
Here's Why Doximity (NYSE:DOCS) Has Caught The Eye Of Investors
author-image

Generative AI And Digital Health Innovations Fuel Robust Revenue Growth And Market Expansion

Accelerating adoption of new products and a client portal, alongside strategic positioning with top clients, suggests sustained revenue expansion.

There's Reason For Concern Over Doximity, Inc.'s (NYSE:DOCS) Massive 27% Price Jump

Aug 18
There's Reason For Concern Over Doximity, Inc.'s (NYSE:DOCS) Massive 27% Price Jump

Doximity (NYSE:DOCS) Looks To Prolong Its Impressive Returns

Aug 10
Doximity (NYSE:DOCS) Looks To Prolong Its Impressive Returns

Doximity Faces Slower Revenue Growth As R&D Costs May Rise

Jul 23

Is Doximity, Inc. (NYSE:DOCS) Trading At A 23% Discount?

Jul 23
Is Doximity, Inc. (NYSE:DOCS) Trading At A 23% Discount?

At US$27.97, Is It Time To Put Doximity, Inc. (NYSE:DOCS) On Your Watch List?

Jul 01
At US$27.97, Is It Time To Put Doximity, Inc. (NYSE:DOCS) On Your Watch List?

Optimistic Investors Push Doximity, Inc. (NYSE:DOCS) Shares Up 26% But Growth Is Lacking

Jun 09
Optimistic Investors Push Doximity, Inc. (NYSE:DOCS) Shares Up 26% But Growth Is Lacking

Doximity Earnings: Better Than Expected, But Still Mixed Outlook (Rating Upgrade)

May 17

Doximity: Significant Upside Remains, But Not Until The Growth Story Returns

Apr 29

Doximity: Rating Upgrade To Buy As Outlook Turns Positive

Feb 21

Doximity: Downside Is Contained, While Upside Depends On Management's Game Plan

Jan 16

Doximity Earnings: Steer Clear Of This Rollercoaster War Of Optimism Vs. Skepticism

Nov 10

Doximity: Adding Value Using AI But Faces Near-Term Risks

Nov 01

Doximity: Rating Downgrade As Investors Shift Focus To The Near-Term Outlook

Aug 24

CEO Compensation Analysis

How has Jeff Tangney's remuneration changed compared to Doximity's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2025n/an/a

US$223m

Dec 31 2024n/an/a

US$201m

Sep 30 2024n/an/a

US$174m

Jun 30 2024n/an/a

US$161m

Mar 31 2024US$299kUS$295k

US$148m

Dec 31 2023n/an/a

US$138m

Sep 30 2023n/an/a

US$123m

Jun 30 2023n/an/a

US$119m

Mar 31 2023US$244kUS$240k

US$113m

Dec 31 2022n/an/a

US$119m

Sep 30 2022n/an/a

US$141m

Jun 30 2022n/an/a

US$148m

Mar 31 2022US$243kUS$240k

US$133m

Dec 31 2021n/an/a

US$107m

Sep 30 2021n/an/a

US$57m

Jun 30 2021n/an/a

US$30m

Mar 31 2021US$21mUS$240k

US$22m

Compensation vs Market: Jeff's total compensation ($USD298.87K) is below average for companies of similar size in the US market ($USD14.05M).

Compensation vs Earnings: Jeff's compensation has increased by more than 20% in the past year.

CEO

Jeff Tangney (52 yo)

15.2yrs
Tenure
US$298,869
Compensation

Mr. Jeffrey A. Tangney, also known as Jeff, Co-Founded Doximity, Inc. in 2010 and has been its Chief Executive Officer and Director since April 2010 and serves as its Chairperson. Mr. Tangney also serves a...

Leadership Team

NamePositionTenureCompensationOwnership
Jeffrey Tangney
Co-Founder15.2yrsUS$298.87k26.51%
$ 2.9b
Nate Gross
Co-Founder & Chief Strategy Officerno dataUS$305.47k0.26%
$ 28.4m
Anna Bryson
Chief Financial Officer4.3yrsUS$3.87m0.17%
$ 18.4m
Jennifer Chaloemtiarana
General Counsel & Corporate Secretary4.8yrsUS$603.94k0.0031%
$ 347.1k
Craig Overpeck
Senior Vice President of Commercial Operations2.1yrsUS$5.21m0.011%
$ 1.3m
Shari Buck
Co-founder and SVP People & Opsno datano datano data
Jey Balachandran
Chief Technology Officerno datano datano data
Perry Gold
Head of Investor Relationsno datano datano data
Bruno Miranda
Senior Vice President of Engineeringno datano datano data
Joel Davis
Senior Vice President of Productno datano datano data
Ben Greenberg
Senior VP & GM Commercial Products2.1yrsno datano data
Lisa Greenbaum
Chief Commercial Officerno datano datano data
4.3yrs
Average Tenure
52yo
Average Age

Experienced Management: DOCS's management team is considered experienced (4.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Jeffrey Tangney
Co-Founder15.2yrsUS$298.87k26.51%
$ 2.9b
Barry Chaiken
Member of Medical Advisory Boardno datano datano data
Timothy Cabral
Independent Director4.8yrsUS$239.94k0%
$ 0
Kevin Spain
Independent Director14.3yrsUS$241.94k0.19%
$ 21.4m
Lawrence Chin
Member of Medical Advisory Boardno datano datano data
Elise Brett
Member of Medical Advisory Boardno datano datano data
Bradley Cohn
Member of Medical Advisory Boardno datano datano data
Alexander Ding
Member of Medical Advisory Boardno datano datano data
Sharon Drost
Member of Medical Advisory Boardno datano datano data
Todd Ferris
Member of Medical Advisory Boardno datano datano data
Harvey Fishman
Member of Medical Advisory Boardno datano datano data
Kira Wampler
Independent Director5.3yrsUS$233.94k0.0055%
$ 603.5k
9.8yrs
Average Tenure
52.5yo
Average Age

Experienced Board: DOCS's board of directors are considered experienced (9.8 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/06/08 14:51
End of Day Share Price 2025/06/06 00:00
Earnings2025/03/31
Annual Earnings2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Doximity, Inc. is covered by 24 analysts. 19 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Vikram KesavabhotlaBaird
Nisala WeerasuriyaBerenberg
Allen LutzBofA Global Research